MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Net income from continuing opera...
Sales and maturities of investme...
Non-cash interest expense for th...
Others
Negative Cash Flow Breakdown
Deferred tax benefit
Net cash used in financing activ...
Net cash used in operating activ...
Others
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Cash Flow
2026-06-30
2025-12-31
Net loss
-
-13,232
Net income from continuing operations
176,358
-
Depreciation and amortization
9
559
Stock-based compensation
8,320
36,072
Accretion/amortization of investments, net
-30
4,734
Amortization of right-of-use assets operating
959
1,864
Non-cash interest expense for the sale of future royalties
41,192
79,893
Deferred tax benefit
-183,699
-
Receivables from collaborative partners
-8,216
-6,915
Prepaid expenses and other assets
3,672
-1,612
Accounts payable and other liabilities
-44,853
-87,327
Income tax receivable
3,245
-
Operating lease liabilities
-1,017
-1,925
Net cash provided by operating activities of continuing operations
-1,402
-
Net cash used in operating activities of discontinued operations
-51,157
-
Net cash (used in) provided by operating activities
-52,559
19,697
Purchase of investments
4,955
196,411
Sales and maturities of investments
47,500
424,530
Net cash provided by investing activities of continuing operations
42,545
-
Purchases of property and equipment
-
87
Net cash used in investing activities of discontinued operations
0
-
Net cash provided by investing activities
42,545
228,032
Proceeds from public offerings, net of underwriters' fees
0
0
Proceeds from issuance of common stock
25,371
14,261
Proceeds from the sale of future royalties
0
0
Principal repayment of liability for sale of future royalties
19,727
76,797
Payments for repurchase of common stock
0
68,626
Payment for net share settlement of equity awards
0
1,451
Payments for offering costs, net
0
0
Payments for issuance costs related to the sale of future royalties
0
0
Net cash provided by (used in) financing activities of continuing operations
5,644
-
Net cash used in financing activities of discontinued operations
-100,000
-
Net cash (used in) provided by financing activities
-94,356
-132,613
Net (decrease) increase in cash and cash equivalents
-104,370
115,116
Cash and cash equivalents, beginning of period
138,196
123,080
Cash and cash equivalents within discontinued operations, beginning of period
100,000
-
Less cash and cash equivalents within discontinued operations, end of period
0
-
Cash and cash equivalents in continued operations, end of period
133,826
238,196
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS).
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
ANAB Cash Flow Sankey Diagram
Sankey diagram visualizing ANAB cash flow for the period
Sales and maturities
of investments
$47,500K
Net cash provided by
investing activities of...
$42,545K
Canceled cashflow
$4,955K
Net cash provided by
investing activities
$42,545K
Proceeds from issuance of
common stock
$25,371K
Purchase of investments
$4,955K
Net (decrease)
increase in cash and cash...
-$104,370K
Canceled cashflow
$42,545K
Net cash provided by
(used in) financing...
$5,644K
Canceled cashflow
$19,727K
Net cash (used in)
provided by financing...
-$94,356K
Net cash (used in)
provided by operating...
-$52,559K
Canceled cashflow
$5,644K
Net income from
continuing operations
$176,358K
Non-cash interest
expense for the sale of...
$41,192K
Stock-based compensation
$8,320K
Receivables from
collaborative partners
-$8,216K
Amortization of right-of-use
assets operating
$959K
Accretion/amortization of investments,
net
-$30K
Depreciation and
amortization
$9K
Principal repayment of
liability for sale of...
$19,727K
Net cash used in
financing activities of...
-$100,000K
Net cash used in
operating activities of...
-$51,157K
Net cash provided by
operating activities of...
-$1,402K
Canceled cashflow
$235,084K
Deferred tax benefit
-$183,699K
Accounts payable and
other liabilities
-$44,853K
Prepaid expenses and
other assets
$3,672K
Income tax receivable
$3,245K
Operating lease
liabilities
-$1,017K
Buy us a coffee
ANAPTYSBIO, INC (ANAB)
ANAPTYSBIO, INC (ANAB)